A biomarker for which a screening test is already available – lack of CDX2 expression – appears to identify the approximately 20% of stage II and ... More »
SAN DIEGO – Tobacco researchers are getting one step closer to identifying young smokers particularly susceptible to the carcinogenic effects of smo... More »
Everolimus improves outcomes in patients with advanced, progressive neuroendocrine tumors of gastrointestinal (GI) or unknown origin regardless of pri... More »
The radiolabeled somatostatin analog 177Lu-Dotatate is efficacious and safe in patients with previously treated advanced midgut neuroendocrine tumors,... More »
SAN FRANCISCO – Hypofractionated radiation therapy, which delivers fewer, larger fractions relative to conventional radiation therapy, can be consid... More »
Observational evidence from studies with large patient numbers suggests statin therapy during treatment for breast cancer may protect against breast c... More »
Bereaved families were substantially more satisfied with end-of-life cancer care when patients did not die in hospital, received more than 3 days of h... More »
SAN FRANCISCO – Men who undergo treatment for metastatic testicular cancer and are alive and disease free a few years later have an excellent progno... More »
The risk of breast cancer relapse decreases consistently for 10 years, then remains stable through 25 years, with ER-positive disease carrying higher ... More »
